Pharma & OTX / Nutraceuticals

The beating heart of PIAM’s activity is its line dedicated to pharmaceutical, OTX, and nutraceutical products.

Founded in 1915 to market the first effective vaccine for tuberculosis treatment, PIAM has evolved over time, remaining true to its core values while addressing the key health and wellness needs expressed by the medical community and the population.

PIAM’s DNA is based on several clearly identified key values: excellence, expertise, continuity, and responsibility.

In practice, this translates into our constant effort to provide doctors and patients with drugs and products that, through pharmaceutical and formulation innovation, facilitate administration and use, thereby improving therapeutic adherence.

To achieve these results, PIAM has committed itself on several fronts:

• A focus on therapeutic areas characterized by high complexity and medical need
• The development of the innovative OTX drug segment
• The creation of a portfolio of nutraceutical products aligned with the growing, widespread demand for well-being

Over time, PIAM has specialized in therapeutic areas marked by high complexity and strong medical need, such as the cardio-metabolic, neuro-geriatric, respiratory, cellular oxidation, and aesthetic medicine fields, among others.

PIAM is also firmly committed to maintaining a constant presence in the treatment of tuberculosis, ensuring the continued availability of essential treatments for this condition.

The core business of our activity focuses on ethical drugs—products aimed at treating clear pathological conditions that require a specific prescription from a doctor.

These drugs are subject to particularly strict regulations, which PIAM adheres to with the utmost rigor, striving to offer the medical community products that align with the latest national and international guidelines while incorporating pharmaceutical and formulation innovations that simplify their use and administration.

In the pharmaceutical landscape, which includes prescription drugs on one side and over-the-counter (OTC) medications on the other, a third category has recently emerged: OTX drugs.

OTX drugs are essentially over-the-counter medications that are dispensed based on the recommendation of the treating physician. This makes the doctor’s role crucial in ensuring therapeutic appropriateness and addressing the specific needs of their patients, which only they can fully understand.

PIAM is active in this emerging sector, offering various drugs characterized by innovative formulation and delivery solutions that ultimately benefit patients.

While traditional pharmaceuticals are aimed at treating well-defined diseases, there is an increasing demand to support the everyday well-being of the population with products that provide the body with targeted nutrients (such as vitamins, minerals, and other compounds) to support physiological functions.

In line with its values of attentiveness to well-being needs that define today’s lifestyle, PIAM has chosen to develop and market a comprehensive range of nutraceutical products designed to support cardiovascular and central nervous system functions.